TY  - GEN
AU  - Fabbro, Michel
AU  - Moore, Kathleen N
AU  - Dorum, Anne
AU  - Tinker, Anna, V
AU  - Mahner, Sven
AU  - Bover Barceló, Isabel
AU  - Banerjee, Susana
AU  - Tognon, Germana
AU  - Goffin, Frederic
AU  - Shapira-Frommer, Ronnie
AU  - Wenham, Robert M
AU  - Hellman, Kristina
AU  - Provencher, Diane
AU  - Harter, Philipp
AU  - Palacio Vazquez, Isabel
AU  - Follana, Philippe
AU  - Pineda, Mario J
AU  - Mirza, Mansoor R
AU  - Hazard, Sebastien J
AU  - Matulonis, Ursula A
PY  - 2019
DO  - 10.1016/j.ygyno.2018.12.009
SN  - 0090-8258
UR  - https://hdl.handle.net/20.500.12105/22682
AB  - Objective. To analyze the safety and efficacy of niraparib in patients aged >= 70 years with recurrent ovarian cancer in the ENGOT-OV16/NOVA trial. Methods. The trial enrolled 2 independent cohorts with histologically diagnosed recurrent ovarian,...
LA  - eng
PB  - Elsevier
KW  - Ovarian cancer
KW  - Older patients
KW  - PARP inhibitors
KW  - Niraparib
KW  - gBRCA mutation
TI  - Efficacy and safety of niraparib as maintenance treatment in older patients (>= 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial
TY  - research article
ER  -